MEDIOCON INC is a trusted global manufacturer and supplier of Nimotuzumab API, providing premium-quality biopharmaceutical active pharmaceutical ingredients for pharmaceutical manufacturing, biologics formulation development, analytical testing, quality control, stability studies, and research applications. Manufactured under stringent quality management systems, our products deliver exceptional purity, consistency, and compliance with international pharmaceutical standards.
Nimotuzumab is a recombinant humanized monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR). It is widely used in oncology pharmaceutical formulations for the treatment of EGFR-expressing cancers, including head and neck cancer, glioma, nasopharyngeal carcinoma, and other solid tumors. By selectively binding to EGFR, Nimotuzumab inhibits tumor cell proliferation, angiogenesis, and metastasis while preserving normal tissues due to its favorable binding characteristics. It is extensively utilized in pharmaceutical research, biosimilar development, analytical method validation, process optimization, stability studies, and quality assurance programs.
MEDIOCON INC supplies premium-quality Nimotuzumab API to pharmaceutical manufacturers, biotechnology companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), universities, research institutes, and analytical laboratories worldwide. Complete documentation including Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and regulatory support documents is available upon request.
| Parameter | Specification |
|---|---|
| Appearance | Clear to Slightly Opalescent Colorless Solution |
| Identification | ELISA, SEC-HPLC & SDS-PAGE Compliant |
| Assay (HPLC) | 95.0% – 105.0% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 6.0 – 7.5 |
| Individual Impurity | NMT 1.00% |
| Total Impurities | NMT 2.00% |
| Melting Point | 2°C to 8°C. |
| Solubility | Freely soluble in aqueous buffer solutions |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Nimotuzumab API Manufacturer & Supplier (CAS 220578-59-6) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Nimotuzumab API Manufacturer & Supplier is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance